Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00202826 · ClinicalTrials.gov registry record · Phase 3
Study of Fluid Collection of the Chest in Children With Pneumonia
A Phase 3 study, sponsored by Corewell Health West.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00202826: Completed Phase 3 study, sponsored by Corewell Health West.
NCT00202826 is a Phase 3 study that has completed, run by Corewell Health West. The registered enrollment target is 30 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00202826, a Phase 3 study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best treatment for children with a fluid collection in the chest associated with an underlying pneumonia. Researchers generally agree that a child with a large fluid collection in the chest need to have the fluid drained in addition to anitbiotics. There have been many treatments studied in children that have been shown to be effective and safe, but the treatments have never been compared to each other in a randomized controlled study. The optimal treatment of pediatric parapneumonic effusions remains controversial. The objective of this study is to compare the use of conventional management (antibiotics with thoracostomy tube placement) with primary thorascopic drainage (see protocol). Our hypothesis is that pediatric patients with parapneumonic effusion, regardless of pleural fluid composition and loculations, have decreased morbidity when treated with early thoroscopic adhesiolysis (VATS) compared with conservative treatment.
Interventions
- PROCEDURE Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-11 |
| Est. Completion | 2004-03 |
| Phase | Phase 3 |
What the finished NCT00202826 record still lists
NCT00202826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainage is the first listed.
NCT00202826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00202826 about?
NCT00202826 is a clinical study titled "Study of Fluid Collection of the Chest in Children With Pneumonia". The purpose of this study is to determine the best treatment for children with a fluid collection in the chest associated with an underlying pneumonia. Researchers generally agree that a child with a large fluid collection in the chest need to have the fluid drained in addition to anitbiotics. There...
What is the current status of trial NCT00202826?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2003-11. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00202826?
The interventions under investigation include: Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainage (PROCEDURE).
Who is sponsoring clinical trial NCT00202826?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00202826's enrollment target sits among peer trials
30 1917th of 2000 higher than 68 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia